Home  
  General Information  
  Archives  
  Services  
  Manuscript Submission  
  About Us  
Volume Cover
Volume 65, Supplement 1:
Interleukin-6 in Rheumatoid Arthritis: A 2007 Update

Links

  • NYU Medical Center
  • NYU Medical Center-Department of Medicine
  • NYU Hospital for Joint Diseases, Division of Rheumatology
  • NYU HJD Department of Orthopaedic Surgery
  • American College of Rheumatology
  • European League Against Rheumatism-EULAR
  • PubMed
  • Current Controversies

Volume 65, Supplement 1:
Interleukin-6 in Rheumatoid Arthritis: A 2007 Update - 2007

Introduction
Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Interleukin-6 - A Key Mediator of Systemic and Local Symptoms in Rheumatoid Arthritis
Interleukin-6 Inhibition and Clinical Efficacy in Rheumatoid Arthritis Treatment - Data from Randomized Clinical Trials
Interleukin-6 Inhibition - Tolerability Profile and Clinical Implications
Monitoring Response to Treatment in Rheumatoid Arthritis - Which Tool is Best Suited for Routine “Real World” Care?
Patient Questionnaires and Formal Education as More Significant Prognostic Markers than Radiographs or Laboratory Tests for Rheumatoid Arthritis Mortality - Limitations of a Biomedical Model to Predict Long-Term Outcomes
AEC Office LLC